Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$718M |
| 2 |
Microsoft
MSFT
|
+$662M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$404M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$709M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 5 |
Home Depot
HD
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.54% |
| 2 | Healthcare | 5.02% |
| 3 | Consumer Discretionary | 4.7% |
| 4 | Financials | 4.22% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Fox Factory Holding Corp
FOXF
$755M
| $2.41M | ﹤0.01% |
22,180
+8,635
| +64% | +$883K |
|
2002
Celldex Therapeutics
CLDX
$2.99B
| $2.4M | ﹤0.01% |
70,834
-47,071
| -40% | -$1.59M |
|
2003
iShares MSCI BIC ETF
BKF
$78.1M
| $2.4M | ﹤0.01% |
70,098
| – | – |
|
2004
Hilltop Holdings
HTH
$2.26B
| $2.4M | ﹤0.01% |
76,197
+48,345
| +174% | +$1.48M |
|
2005
Neogen
NEOG
$2.63B
| $2.39M | ﹤0.01% |
110,032
+52,878
| +93% | +$956K |
|
2006
Essential Utilities
WTRG
$11.3B
| $2.39M | ﹤0.01% |
59,951
-61,367
| -51% | -$2.57M |
|
|
TE
2007
CALL
T1 Energy
TE
$1.16B
| $2.39M | ﹤0.01% |
255,100
| – | – |
|
2008
Shift4
FOUR
$4.2B
| $2.38M | ﹤0.01% |
35,102
+2,891
| +9% | +$190K |
|
2009
Simply Good Foods
SMPL
$901M
| $2.38M | ﹤0.01% |
65,127
+26,914
| +70% | +$990K |
|
2010
Avnet
AVT
$7.29B
| $2.37M | ﹤0.01% |
47,074
-9,101
| -16% | -$401K |
|
2011
Vanguard Industrials ETF
VIS
$8.1B
| $2.37M | ﹤0.01% |
11,534
+1,832
| +19% | +$350K |
|
2012
Ryanair
RYAAY
$30.4B
| $2.37M | ﹤0.01% |
53,520
-7,425
| -12% | -$299K |
|
|
ALLK
2013
DELISTED
Allakos
ALLK
| $2.37M | ﹤0.01% |
542,688
-292,211
| -35% | -$1.31M |
|
|
ITCI
2014
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.37M | ﹤0.01% |
37,350
+25,832
| +224% | +$1.61M |
|
2015
Lloyds Banking Group
LYG
$89.5B
| $2.36M | ﹤0.01% |
1,073,087
+87,196
| +9% | +$200K |
|
2016
Bloom Energy
BE
$60.6B
| $2.36M | ﹤0.01% |
144,338
+63,250
| +78% | +$1.02M |
|
2017
Cathay General Bancorp
CATY
$4.22B
| $2.36M | ﹤0.01% |
73,268
+56,457
| +336% | +$1.79M |
|
2018
Western Midstream Partners
WES
$19.2B
| $2.36M | ﹤0.01% |
88,889
+33,728
| +61% | +$887K |
|
2019
Brighthouse Financial
BHF
$3.56B
| $2.36M | ﹤0.01% |
49,755
+28,689
| +136% | +$1.24M |
|
2020
Robinhood
HOOD
$77.8B
| $2.36M | ﹤0.01% |
236,019
-16,294
| -6% | -$152K |
|
2021
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $2.35M | ﹤0.01% |
46,849
-198,501
| -81% | -$9.97M |
|
2022
PUT
Equinix
EQIX
$101B
| $2.35M | ﹤0.01% |
3,000
| – | – |
|
2023
CALL
Ionis Pharmaceuticals
IONS
$8.6B
| $2.35M | ﹤0.01% |
57,300
| – | – |
|
|
2024
PUT
Ionis Pharmaceuticals
IONS
$8.6B
| $2.35M | ﹤0.01% |
57,300
| – | – |
|
2025
PUT
Cognizant
CTSH
$24.9B
| $2.35M | ﹤0.01% |
36,000
| – | – |
|
Similar funds
Citigroup's Q2 2023 Portfolio in Review
As of Q2 2023, Citigroup held 5,906 positions worth $153B, up 6.9% from $143B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup's Q2 2023 filing shows 463 new, 2,756 increased, 1,590 reduced and 354 closed positions. Its largest new stake was Vesta Real Estate: 3,353,619 shares worth $108M. The largest sale was iShares Russell 2000 ETF, an estimated $713M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q2 2023 buy was Vesta Real Estate: 3,353,619 shares worth $108M.
- Citigroup added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $718M increase.
- Citigroup's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited DCP Midstream, LP in Q2 2023, selling an estimated $198M.
- Citigroup's ten largest holdings make up 34% of its $153B portfolio in Q2 2023.
- Citigroup opened 463 new positions and closed 354 in Q2 2023.
- Citigroup's portfolio value rose 6.9% quarter-over-quarter to $153B.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.